(i) Infectious Diseases (Viral hepatitis, TB disease): identifying components of disease aetiology and management that can be influenced for better health outcomes of patients.

(ii) Molecular Epidemiology: identification biomarkers for disease pathogenesis, risk and prevention and

(iii) Biomarkers for immune dynamism during infection: for better disease diagnosis and prognosis